Radioligand concerns overruled by Minister
By Megan Brodie 1 year ago | In Companies, Products, Reimbursement- 1 year ago
18 June 2025 Novartis attempted to delay public funding of compounded radioligand therapy for prostate…
This is subscriber-only content. Please login to continue reading.